← SynDRA
PIMECROLIMUS
SynDRA canonical compound SYN0023128 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CYP3A5 | FKBP1A |
|---|
| Mechanism of action | calcineurin inhibitor |
|---|
| Indication | eczema |
|---|
| Disease area | dermatology |
|---|
All known targets
- FKBP1A
- CYP3A5
- Fkbp1a
- IFNG
- IL2
- IL5
- PPP3CA
- PPP3CC
Mechanisms of action (all sources)
- FKBP1A INHIBITOR
- FK506-binding protein 1A inhibitor
- calcineurin inhibitor
- PPP3CA INHIBITOR
Drug classes
- Calcineurin Inhibitor Immunosuppressant
- Calcineurin Inhibitors
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Dermatologic Agents
- Enzyme Inhibitors
- Immunologic Factors
- Immunosuppressive Agents
- Peripheral Nervous System Agents
ATC classes
- D11A · OTHER DERMATOLOGICAL PREPARATIONS
Cross-references
Synonyms
- elidel
- picrolimus
- (-)-pimecrolimus
- SDZ-ASM-981
- Elidel
- ASM-981
- ASM-998
- Elidel (TN)
- Pimecrolimus [USAN:INN:BAN]
- Pimecrolimus (JAN/USAN/INN)
- 33-epi-Chloro-33-desoxyascomycin
- 7KYV510875
- (-)-PIMECROLIMUS
- SDZ ASM-981
- DTXCID0026674
- Pimecrolimusum
- RefChem:56730
- D11AX15
- MFCD00901792
- C43H68ClNO11
- Pimecrolimus?
- UNII-7KYV510875
- NCGC00167506-01
- PIMECROLIMUS [MI]
- PIMECROLIMUS [INN]
- PIMECROLIMUS [JAN]
- PIMECROLIMUS [USAN]
- PIMECROLIMUS [VANDF]
- PIMECROLIMUS [MART.]
- PIMECROLIMUS [WHO-DD]
- SCHEMBL438880
- GTPL6783
- orb1305220
- Pimecrolimus, >=97% (HPLC)
- CHEBI:135888
- KASDHRXLYQOAKZ-XDSKOBMDSA-N
- PIMECROLIMUS [ORANGE BOOK]
- EX-A2138
Reported adverse events
- Acne
- Arthralgia
- Asthma
- Bronchitis
- Conjunctivitis
- Constipation
- Cough
- Epistaxis
- Erythema
- Folliculitis
- Gastroenteritis
- Headache
Look up PIMECROLIMUS in the interactive SynDRA portal →